A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa.

OBJECTIVE The goals of the current study were threefold: 1) to examine whether the hypofunctional 7R allele of the DRD4 gene contributes to maximal lifetime body mass in women with BN; 2) to determine whether the BDNF gene contributes to maximal BMI on its own, and 3) to explore possible BDNF/DRD4 gene-gene interactions in mediating maximum lifetime BMIs in BN. METHOD We tested two General Linear Models predicting maximum lifetime BMI with the exon 3 VNTR polymorphism of the dopamine-4 receptor gene (DRD4) and either the Val66Met or the -270C/T polymorphism of BDNF respectively in 163 female probands with BN, purging subtype. RESULTS In these bulimic subjects, the hypofunctional 7R allele of DRD4 predicted maximal BMI (p < .01). There was also a significant interaction between the DRD4 gene and the BDNF gene in predicting maximal BMI. The Val66Met rather than the 270C/T polymorphism of BDNF interacting with DRD4 predicted maximum BMI in this BN sample (p < .01). Probands carrying both the hypofunctional 7R allele of DRD4 and the Met66 allele of BDNF had significantly higher maximal BMI than did probands in the other gene-gene interaction groups. CONCLUSION These results provide further evidence that the hypofunctional 7R allele of DRD4 contributes to weight gain in women with BN and that the BDNF gene interacts with DRD4 to influence weight regulation in these subjects.

[1]  M. Maj,et al.  The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder , 2006, Neuroscience Letters.

[2]  J. Kornhuber,et al.  Association of catecholamine-O-methyltransferase and 5-HTTLPR genotype with eating disorder-related behavior and attitudes in females with eating disorders , 2006, Psychiatric genetics.

[3]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[4]  J. Kennedy,et al.  The serotonin-1Dβ receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa , 2006, European Neuropsychopharmacology.

[5]  H. Steiger,et al.  Association of the promoter polymorphism −1438G/A of the 5‐HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  K. Hutchison,et al.  Cue-elicited craving for food: a fresh approach to the study of binge eating , 2005, Appetite.

[7]  D. Collier,et al.  Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations , 2005, European Journal of Human Genetics.

[8]  H. Steiger,et al.  The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. , 2005, The International journal of eating disorders.

[9]  P. Muglia,et al.  The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: An evolutionary perspective , 2004, Biological Psychiatry.

[10]  D. Collier,et al.  Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. , 2004, Human molecular genetics.

[11]  V. Barrios,et al.  Analysis of the −1438 G/A polymorphism of the 5-HT2A serotonin receptor gene in bulimia nervosa patients with or without a history of anorexia nervosa , 2004, Psychiatric genetics.

[12]  P. Muglia,et al.  Childhood Inattention and Dysphoria and Adult Obesity Associated with the Dopamine D4 receptor Gene in Overeating Women with Seasonal Affective Disorder , 2004, Neuropsychopharmacology.

[13]  M. Narita,et al.  Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine , 2003, Neuroscience.

[14]  E. H. Goulding,et al.  Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor , 2003, Nature Neuroscience.

[15]  G. Uhl,et al.  Reduced Behavioral Effects of Cocaine in Heterozygous Brain-Derived Neurotrophic Factor (BDNF) Knockout Mice , 2003, Neuropsychopharmacology.

[16]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[17]  S. Bacanu,et al.  Significant linkage on chromosome 10p in families with bulimia nervosa. , 2003, American journal of human genetics.

[18]  M. Gratacós,et al.  Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type , 2003, Molecular Psychiatry.

[19]  David Wittrock,et al.  An evaluation of the relationship between mood and binge eating in the natural environment using ecological momentary assessment. , 2002, The International journal of eating disorders.

[20]  S. Fetissov,et al.  Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[21]  M Strober,et al.  Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. , 2002, American journal of human genetics.

[22]  S. Kennedy,et al.  Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa , 2001, Biological Psychiatry.

[23]  S. Higuchi,et al.  Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients , 2001, Biological Psychiatry.

[24]  P. Sokoloff,et al.  BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization , 2001, Nature.

[25]  Jean Logan,et al.  Brain dopamine and obesity , 2001, The Lancet.

[26]  A. Rissanen,et al.  Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns , 2000, International Journal of Obesity.

[27]  L. Parada,et al.  BDNF regulates eating behavior and locomotor activity in mice , 2000, The EMBO journal.

[28]  D. Comings,et al.  Reward deficiency syndrome: genetic aspects of behavioral disorders. , 2000, Progress in brain research.

[29]  F. Poustka,et al.  No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight, and obesity. , 1999, American journal of medical genetics.

[30]  JaneR . Taylor,et al.  Enhancement of Locomotor Activity and Conditioned Reward to Cocaine by Brain-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.

[31]  Koki Inoue,et al.  Prefrontal and striatal dopamine metabolism during enhanced rebound hyperphagia induced by space restriction—a rat model of binge eating , 1998, Biological Psychiatry.

[32]  Masataka Watanabe Reward expectancy in primate prefrental neurons , 1996, Nature.

[33]  D. Comings,et al.  The D2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome , 1996, Journal of the Royal Society of Medicine.

[34]  Stanley J Watson,et al.  Dopamine Receptor mRNA Expression in Human Striatum and Neocortex , 1996, Neuropsychopharmacology.

[35]  H. Thoenen Neurotrophins and Neuronal Plasticity , 1995, Science.

[36]  H. V. Van Tol,et al.  Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants , 1995, Journal of neurochemistry.

[37]  D S Goldbloom,et al.  Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups. , 1995, The American journal of psychiatry.

[38]  K K Kidd,et al.  A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. , 1993, Human molecular genetics.

[39]  F. Hefti,et al.  The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth FACTOR-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture , 1993, Neuroscience.

[40]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[41]  F. Hefti,et al.  Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.